Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
iBio Inc, Medical Devices Deals, 2012 to YTD 2018 10
iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
iBio Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
iBio Enters into Agreement with AzarGen Biotechnologies 13
Texas A&M University Enters into Agreement with iBio 14
iBio Amends Agreement with Medical University of South Carolina 15
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 16
iBio Enters into Agreement with Novici Biotech 17
Licensing Agreements 18
iBio Amends Licensing Agreement with US University 18
iBio Enters into Licensing Agreement with University of Pittsburgh 19
iBio Enters Into Licensing Agreement With Caliber Biotherapeutics 20
iBio Enters into Licensing Agreement with Caliber Biotherapeutics 22
iBio Extends Licensing Agreement with Fraunhofer 23
iBio Extends its Licensing Agreement with Bio-Manguinhos 24
Equity Offering 25
iBio Raises USD16 Million in Public Offering of Shares 25
iBio Raises USD4.5 Million in Public Offering of Shares 26
iBio to Raise Funds in Public Offering of Shares 27
iBio Raises USD1 Million in First Tranche of Private Placement of Shares 28
iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares 30
iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares 31
iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants 32
iBio Raises USD0.9 Million in Private Placement of Shares up on Exercise of Warrants 33
iBio Plans to Raise up to USD15 Million in Private Placement of Shares 34
iBio Raises USD10 Million in Private Placemet of Shares 35
iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares 36
Ibio Completes Public Offering Of Units For US$4 Million 37
iBio, Biotechnology Company, Completes Public Offering Of Common Stock For US$10 Million 38
iBio Inc – Key Competitors 39
iBio Inc – Key Employees 40
iBio Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Legal and Regulatory 42
Nov 06, 2017: iBio Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court 42
Product News 43
Mar 14, 2018: iBio Selects Lead Candidate for its Fibrosis Therapeutics Program 43
03/14/2018: iBio Selects Lead Candidate for its Fibrosis Therapeutics Program 44
Mar 07, 2018: iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics 45
Other Significant Developments 46
Oct 30, 2017: iBio CDMO President to Co-Chair South African Molecular Pharming Conference 46
May 04, 2017: iBio Provides Corporate Update at Annual Shareholders Meeting 47
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
iBio Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
iBio Inc, Deals By Therapy Area, 2012 to YTD 2018 9
iBio Inc, Medical Devices Deals, 2012 to YTD 2018 10
iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
iBio Enters into Agreement with AzarGen Biotechnologies 13
Texas A&M University Enters into Agreement with iBio 14
iBio Amends Agreement with Medical University of South Carolina 15
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 16
iBio Enters into Agreement with Novici Biotech 17
iBio Amends Licensing Agreement with US University 18
iBio Enters into Licensing Agreement with University of Pittsburgh 19
iBio Enters Into Licensing Agreement With Caliber Biotherapeutics 20
iBio Enters into Licensing Agreement with Caliber Biotherapeutics 22
iBio Extends Licensing Agreement with Fraunhofer 23
iBio Extends its Licensing Agreement with Bio-Manguinhos 24
iBio Raises USD16 Million in Public Offering of Shares 25
iBio Raises USD4.5 Million in Public Offering of Shares 26
iBio to Raise Funds in Public Offering of Shares 27
iBio Raises USD1 Million in First Tranche of Private Placement of Shares 28
iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares 30
iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares 31
iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants 32
iBio Raises USD0.9 Million in Private Placement of Shares up on Exercise of Warrants 33
iBio Plans to Raise up to USD15 Million in Private Placement of Shares 34
iBio Raises USD10 Million in Private Placemet of Shares 35
iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares 36
Ibio Completes Public Offering Of Units For US$4 Million 37
iBio, Biotechnology Company, Completes Public Offering Of Common Stock For US$10 Million 38
iBio Inc, Key Competitors 39
iBio Inc, Key Employees 40
iBio Inc, Other Locations 41
iBio Inc, Subsidiaries 41
List of Figures
iBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
iBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
iBio Inc, Medical Devices Deals, 2012 to YTD 2018 10